Molina Healthcare Reports Q3 2026 Results Amid Rising Medical Costs and Medicaid Contract Challenges
Molina Healthcare (MOH) reported a significant decline in third-quarter adjusted earnings per share, falling 52% to $0.89. This downturn was primarily driven by an elevated consolidated medical care ratio (MCR) of 92.9%, reflecting higher utilization and acuity shifts across its primary segments. Premium revenue for the quarter reached $10.5 billion, a 4% year-over-year decrease attributed to lower membership in the Medicaid and Marketplace segments. Despite current headwinds, management reaffirmed its full-year 2026 adjusted EPS guidance of at least $5.25, which accounts for specific losses related to the Florida Medicaid contract implementation and discontinued products. Looking toward 2027, the company has adjusted its premium revenue outlook downward to at least $45 billion due to judicial delays regarding new contracts in Georgia and Texas, though it maintains a long-term positive earnings trajectory through strategic initiatives.
Topics: earnings report Medicaid medical care ratio Medicare revenue guidance